Product Detail

Praziquantel, Febantel, Pyrantel Indication: Treatment mixed infections by nematodes and cestodes in dogs.

Features

For Dogs 2.5kg - 20kg

Treatment of mixed infections by nematodes and cestodes in dogs

Safety Warning

SPECIAL WARNING(S), IF NECESSARY: Do not use simultaneously with piperazine compounds as the anthelmintic effects of pyrantel and piperazine may be antagonized. Tapeworm infestation is certain to re-occur unless control of intermediate hosts such as fleas, mice etc. is undertaken. Tapeworm infestation is unlikely in pups less than 6 weeks of age. Do not use in animals with a known sensitivity to the active ingredients or to any of the excipients. Teratogenic effects attributed to high doses of febantel have been reported in sheep and rats. No studies have been performed in dogs during early pregnancy. Use of the product during pregnancy should be in accordance with a benefit risk assessment by the responsible veterinarian. It is recommended that the product is not used in dogs during the first 4 weeks of pregnancy. Do not exceed the stated dose when treating pregnant bitches. FOR ANIMAL TREATMENT ONLY Keep out of the sight and reach of children

Preparation & Usage

Method and Route(s) of Administration: Read the package leaflet before use. For single oral administration. 1 tablet per 10 kg bodyweight.

Storage Guidelines

Do not use after expiry date. This veterinary medicinal product does not require any special storage conditions. Please refer to package leaflet for disposal advice. Discard any unused divided tablets.

Storage Type

Manufacturer Address

Marketing Authorisation Holder: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway., Ireland.

Company Name

Chanelle Pharmaceuticals Manufacturing Ltd.

Company Address

Loughrea, Co. Galway., Ireland.

Return To

Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway., Ireland.